Authors: BELANGER K MOORE M DIONNE J MCLEAN M PROULX L HUNT W MARSOLAIS C BAKER S WAINMAN N SEYMOUR L

Citation: K. Belanger et al., A PHASE-I STUDY OF THE NOVEL L-NUCLEOSIDE ANALOG BCH-4556 GIVEN EVERY21 DAYS, Annals of oncology, 9, 1998, pp. 601-601

Authors: SIU LL OZA AM EISENHAUER EA FIRBY PS THIESSEN JJ MICHAEL M WAINMAN N MANZO J FELD R GOLDBERG RA MOORE MJ

Citation: Ll. Siu et al., PHASE-I AND PHARMACOLOGICAL STUDY OF 9-AMINOCAMPTOTHECIN COLLOIDAL DISPERSION FORMULATION GIVEN AS A 24-HOUR CONTINUOUS-INFUSION WEEKLY TIMES 4 EVERY 5 WEEKS, Journal of clinical oncology, 16(3), 1998, pp. 1122-1130

Authors: MACDONALD D CAIRNCROSS G STEWART D FORSYTH P SAWKA C WAINMAN N EISENHAUER E

Citation: D. Macdonald et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA, Annals of oncology, 7(2), 1996, pp. 205-207

Authors: FORSYTH P CAIRNCROSS G STEWART D GOODYEAR M WAINMAN N EISENHAUER E

Citation: P. Forsyth et al., PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Investigational new drugs, 14(2), 1996, pp. 203-206

Authors: CAIRNCROSS G MACDONALD D LUDWIN S LEE D CASCINO T BUCKNER J FULTON D DROPCHO E STEWART D SCHOLD C WAINMAN N EISENHAUER E

Citation: G. Cairncross et al., CHEMOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIOMA, Journal of clinical oncology, 12(10), 1994, pp. 2013-2021

Authors: BELANGER K JOLIVET J MAROUN J STEWART D GRILLOLOPEZ A WHITFIELD L WAINMAN N EISENHAUER E

Citation: K. Belanger et al., PHASE-I PHARMACOKINETIC STUDY OF DUP-937, A NEW ANTHRAPYRAZOLE, Investigational new drugs, 11(4), 1993, pp. 301-308